pharma · No medical condition. · Breast cancer
George Institute for
The George Institute
George Institute is a pharma organization headquartered in KOLKATA, IN. Primary therapeutic focus areas include No medical condition., Breast cancer, Metastatic colorectal cancer, Prostate Cancer, advanced/metastatic HER
Sydney, NSW 2042, AU HQ
1999 Founded
841 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Sydney, NSW 2042, AU
- Founded
- 1999
- Employees
- 841
- Programs
- 406
- Drugs
- 522
- Patents
- 0
Pentasa Sachet depotgranulat for Lynch syndrome, which is increa…
Phase 2 · small molecule · Lynch syndrome, which is increasing the risk of developing colorectal cancer
Pentasa Sachet depotgranulat for Lynch syndrome, which is increa… for Lynch syndrome, which is increasing the risk of developing colorectal cancer is a Phase 2 program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- The George Institute
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Lynch syndrome, which is increasing the risk of developing colorectal cancer
- Status
- active
- Trials
- 1